Tenderwize
Back to tender search

Pharmaceutical rebate agreements with accession option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline Nov 01, 2027 · 440 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittelrabattverträge mit Beitrittsoption

20/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

20 / 100

Complexity

45 / 100

Risk factors

No estimated value, award criteria, or eligibility criteria are provided. This makes it impossible to assess the tender...

The notice states it is not a public procurement under EU Directive 2014/24/EU, yet it uses the open procedure label. T...

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 2 lots
  • Duration until Dec 2027
  • Supply of pharmaceutical products containing Aflibercept 40 mg/ml in two forms: vials (Durchstechflaschen) and pre-filled syringes (Fertigspritzen).
  • Framework agreement with accession option (Beitrittsoption) allowing additional parties to join.
Show full summary

This is a German framework agreement with accession option for pharmaceutical products (Aflibercept) issued by BARMER Beschaffung und Vergabe. It consists of two lots: one for vials (40 mg/ml) and one for pre-filled syringes (40 mg/ml). The notice explicitly states it is not a public procurement under EU directives, but uses an open procedure format. No estimated values, award criteria, or eligibility criteria are provided. The submission deadline is November 1, 2027, with a two-year contract period starting December 1, 2025. The buyer is a health insurance body. The tender is available only electronically via the buyer's platform. Documents were not analyzed beyond the XML notice.

Risks

No estimated value, award criteria, or eligibility criteria are provided. This makes it impossible to assess the tender...

The notice states it is not a public procurement under EU Directive 2014/24/EU, yet it uses the open procedure label. T...

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Maximum of 2 lots can be awarded to one tenderer (MaximumLotsAwardedNumeric: 2).
  • Variants are not allowed.

Administrative

  • Tenders must be submitted electronically via the buyer's platform (Open portal).

Requirements may be incomplete.

Buyer

Location

Wuppertal, DEU

Identifier

992-80322-57

Activity

Health

Lots (2)

LOT-0001

Aflibercept (Vials 40 mg/ml)

Supply of medicinal products containing Aflibercept in vial form (40 mg/ml). Framework agreement with accession option.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Nov 2025 - Dec 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 01, 2027

LOT-0002

Aflibercept (Pre-filled Syringes 40 mg/ml)

Supply of medicinal products containing Aflibercept in pre-filled syringe form (40 mg/ml). Framework agreement with accession option.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Nov 2025 - Dec 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 01, 2027

Procurement Details

Publication date
20 Oct 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
692194-2025

Documents (1)

Similar tenders